Telemonitoring and Intermediate Care
To the Editor:
COPD is a progressive disease responsible for signifi cant morbidity and mortality. 1 In recent years, intermediate care has been developed by secondary and primary health professionals to provide a seamless approach to the delivery of intersectoral patient care. 2 The intermediate model of care improves choice for patients and aims to reduce morbidity from COPD exacerbations through community-based interventions, such as hospital at home and early supported discharge schemes. 3 Exacerbations of COPD have been linked with frequent emergency attendances, 4 hospitalization, 4 and a reduction in quality of life 5 and lung function, 6 and patients who experience an exacerbation may benefi t from an intermediate model of care. 2 The monitoring of intermediate care patients has recently gained prominence with the advent of health technology. 7 We defi ned telemonitoring within intermediate care as the daily use of health technology by clinical staff at a health-care facility to remotely monitor a patient's progress. The ability to have surveillance of the patient's clinical data while the patient is at home is proving to be of interest to clinicians and commissioners of services. 8 However, telemonitoring in the intermediate care patient population may provide information that previously proved to be elusive to capture and could contribute to a central hub of clinical decision making. We recently reviewed . 1,000 articles and were able to identify a very small number of high-quality studies ( Table 1 ) that have attempted to use telemonitoring as an adjunct clinical tool within intermediate care alongside or as a comparison with "best" guideline-based practice. Many studies that we reviewed simply described the technology. Our primary outcome measures were hospital readmission rates, length of stay, unscheduled health care, and exacerbations at home, and secondary outcomes were changes in health behavior and quality of life. Our review found a lack of telemonitoring homogeneity because of the different technologies used in these studies and the fact that many studies reported high attrition rates. Of particular interest, some studies reduced readmission rates and length of stay; however, these improvements were not mirrored in positive changes in quality-of-life scores. Although it appears that several studies did seem to show a change in the number of unscheduled care events, the differing types of technology used, their monitoring schedules, patient populations, and the lack of a guideline-based best practice comparator according to the intermediate care guideline 2 brings a challenge to the clinical interpretation of these results. It has been previously noted that intermediate care may not be a suitable option for 75% of patients with COPD presenting to hospitals for assessment of an exacerbation, 13 and technology reduces this potential number of patients further. On completing this review, we fi nd it diffi cult to recommend to commissioners the addition of this technology to intermediate care and see the need for better quality studies in the future that can establish a clear role for telemonitoring as an adjunct to intermediate care.
